[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Alberty, 1994 - Google Patents

Lipoprotein (a) concentration in various hyperlipidemias

Alberty, 1994

View PDF
Document ID
11649183293367040242
Author
Alberty R
Publication year
Publication venue
Clinica chimica acta

External Links

Snippet

Recent studies suggest an association of lipoprotein (a)(Lp (a)) with atherosclerotic vascular disease. In well-defined disease groups, the incidence of serum Lp (a) concentration greater than 300 mg/l varied from 27% in patients with thrombosis [I] to 55% in end-stage renal …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/08—Sphingolipids

Similar Documents

Publication Publication Date Title
Blum Dynamics of apolipoprotein E metabolism in humans
Warnick et al. Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays
Bersot et al. Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein [a] and that cause lipid accumulation in macrophages.
Lee et al. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency
Cheung et al. Increased lipase inhibition in uremia: identification of pre-β-HDL as a major inhibitor in normal and uremic plasma
US4746605A (en) Process and a reagent for the determination of low density lipoproteins (LDL)
Steinberg et al. Metabolic studies in an unusual case of asymptomatic familial hypobetalipoproteinemia with hypoalphalipoproteinemia and fasting chylomicronemia
EP0767914A1 (en) Antibodies to lipoproteins and apolipoproteins and methods of use thereof
Duhamel et al. Plasma lipoprotein and apolipoprotein profile in alcoholic patients with and without liver disease: on the relative roles of alcohol and liver injury
US5407836A (en) Process and reagent for the determination of low density lipoproteins (LDL)
CA2172247A1 (en) Method of assaying oxidized lipoprotein and application thereof
JP2002539458A (en) Method and device for detecting APOA and APOB in saliva and their ratio
Shore et al. Abnormal high density lipoproteins in cerebrotendinous xanthomatosis.
KRÄMER‐GUTH et al. Structural and compositional modifications of diabetic low‐density lipoproteins influence their receptor‐mediated uptake by hepatocytes
Alaupovic et al. Separation and identification of apo-B-containing lipoprotein particles in normolipidemic subjects and patients with hyperlipoproteinemias
Alberty Lipoprotein (a) concentration in various hyperlipidemias
JP3869471B2 (en) Method for specific measurement of HDL cholesterol and composition for measurement
AU716560B2 (en) Method for the isolation of lipoprotein (A) allowing for the subsequent quantification of its mass and cholesterol content
Tiyyagura et al. Standard lipid profile
WO1981001199A1 (en) Method and kit for the clinical separation of alpha-and beta-lipoproteins
Molinari et al. Immunoturbidimetric determination of lipoprotein (a): improvement in the measurement of turbid and triglyceride-rich samples
Okada et al. Lipid analyses for the management of vascular diseases
Crook et al. Serum apolipoprotein H and its relationship to lipids and other apolipoproteins in normal human men and women
Yao et al. Biochemical studies in a patient with a Tangier syndrome
Yamashita et al. A delayed-addition enzyme immunoassay for the relative cholesteryl ester transfer protein mass in patients with deficient plasma cholesteryl ester transfer activity